Studies for developing a laboratory diagnostic system for cancers by means of PCR that is applicale to clinical samples such as urine and stool
研究开发适用于尿液和粪便等临床样本的 PCR 癌症实验室诊断系统
基本信息
- 批准号:05557059
- 负责人:
- 金额:$ 10.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Developmental Scientific Research (B)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this project, we studied the following points : (1)Simple methods extracting DNA from clinical materials such as urine and stool. (2)Prevention of carry-over contamination of PCR products. (3)Detection of point mutaion by non-radioisotpoe probes. (4)New method for detecting point mutation ocurring at random position. As for the method of DNA extraction, we compared 4 methods including commercial glass beads method. Our results indicated that the glass beads method with a minor modification was very simple and worked efficiently, and the DNA sample obtained was good for PCR analysis. For preventing the carry-over contamination, we tested the Uracyl N-glycosylase system. It was confirmed that dUTP-Uracyl N-glycosylase system can be the only practical method to prevent carry-over contamination in the PCR performed in the conventional laboratories not specificaly equipped for PCR studies. We tried to detect a point mutation in the Ki-ras gene from clinical samples using non-radioisotope probes. Chemiluminescence system proved to be suitable for this purpose, because other staining method resulted in high background signals. We also tried to establish a new method for detecting a point mutaion ocurring at a random position. The first plan was based on the specific digestion by S1 nuclease of the heteroduplex formed by wild type and mutated genes after hybridization. It was revealed that S1 nuclease digestion was not specific enough for our purpose. Trials of other methods are now under way.
在本项目中,我们研究了以下几点:(1)从尿液、粪便等临床材料中提取DNA的简单方法。 (2)防止PCR产物的残留污染。 (3)非放射性同位素探针点突变检测。 (4)检测随机位置点突变的新方法。对于DNA提取方法,我们比较了包括商业玻璃珠法在内的4种方法。我们的结果表明,经过细微修改的玻璃珠方法非常简单且有效,并且获得的 DNA 样品适合 PCR 分析。为了防止残留污染,我们测试了尿酰 N-糖基化酶系统。经证实,dUTP-尿酰基N-糖基化酶系统可以是防止在未专门配备用于PCR研究的常规实验室中进行的PCR中残留污染的唯一实用方法。我们尝试使用非放射性同位素探针从临床样本中检测 Ki-ras 基因的点突变。化学发光系统被证明适合此目的,因为其他染色方法会导致高背景信号。我们还尝试建立一种新方法来检测随机位置发生的点突变。第一个方案是基于S1核酸酶对野生型和突变基因杂交后形成的异源双链体进行特异性消化。结果表明,S1 核酸酶消化对于我们的目的来说不够具体。其他方法的试验正在进行中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WATANABE Toshiki其他文献
WATANABE Toshiki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WATANABE Toshiki', 18)}}的其他基金
HTLV-1 hijacks T-cell differentiation/function by deregulatingHelios gene expression
HTLV-1通过解除Helios基因表达调控来劫持T细胞分化/功能
- 批准号:
23659484 - 财政年份:2011
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Oncogene addiction of ATL cells and abnormal Polycomb-miRNA-signal transduction
ATL细胞的癌基因成瘾和异常的Polycomb-miRNA信号转导
- 批准号:
23390250 - 财政年份:2011
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pursuit of a new system for a high throughput screening of drugs to develop a new strategy of prevention and treatment of ATL
追求高通量药物筛选新系统,制定ATL防治新策略
- 批准号:
20390267 - 财政年份:2008
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Abnormalities in TCR signal transduction in T cell non-Hodgkin's lymphoma as a basis for a new classification system.
T 细胞非霍奇金淋巴瘤中 TCR 信号转导异常作为新分类系统的基础。
- 批准号:
18390111 - 财政年份:2006
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of zooxanthellate genes that are involved in symbiosis with a reef coral, and analyses of their function and expression
鉴定与珊瑚礁共生相关的虫黄藻基因,并分析其功能和表达
- 批准号:
16510157 - 财政年份:2004
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploration of sub-seafloor methanehydrate using artificial current source ocean-bottom electromagnetic method and its reservoir estimation
人工电流源海底电磁法勘探海底甲烷水合物及其储层估算
- 批准号:
16360449 - 财政年份:2004
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on abnormalities of membrane receptor signaling in malignant lymphoma cells as a basis of diagnosis and treatment
恶性淋巴瘤细胞膜受体信号异常作为诊断和治疗依据的研究
- 批准号:
16390103 - 财政年份:2004
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular analysis of aberrant signal transduction of membrane receptors as a basis for diagnosis and treatment of malignant lymphomas
膜受体异常信号转导的分子分析作为恶性淋巴瘤诊断和治疗的基础
- 批准号:
14370067 - 财政年份:2002
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular studies on the formation of calcified hard tissues in marine crustaceans
海洋甲壳动物钙化硬组织形成的分子研究
- 批准号:
08833004 - 财政年份:1996
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of genes involved in the multistep leukemogenesis of ATL
参与 ATL 多步白血病发生的基因的表征
- 批准号:
08457273 - 财政年份:1996
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
基于单细胞组学的癌症异质性解析和个性化给药方案研究
- 批准号:62373093
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
癌症细胞膜上多肽原位自组装及其在免疫调节剂前药递送中的应用
- 批准号:32301103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多组学特征整合的癌症诊疗靶点识别方法研究
- 批准号:62302088
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
可代谢调控弱碱性钠盐纳米材料的控制合成及其在增强癌症免疫治疗中的应用
- 批准号:52372273
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
双重生物响应性自佐剂聚多肽载体构建高效mRNA癌症疫苗
- 批准号:52373299
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
非癌基因成瘾作为胰腺癌的靶向治疗
- 批准号:
8601296 - 财政年份:2013
- 资助金额:
$ 10.05万 - 项目类别:
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
非癌基因成瘾作为胰腺癌的靶向治疗
- 批准号:
8427550 - 财政年份:2013
- 资助金额:
$ 10.05万 - 项目类别:
Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator
胰腺癌中的 Ki-Ras 信号转导:新型 Akt 调节剂的作用
- 批准号:
8545744 - 财政年份:2012
- 资助金额:
$ 10.05万 - 项目类别:
Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator
胰腺癌中的 Ki-Ras 信号转导:新型 Akt 调节剂的作用
- 批准号:
8362895 - 财政年份:2012
- 资助金额:
$ 10.05万 - 项目类别:
RECOMBINANT ANTIBODIES AGAINST PROSTATE CANCER ANTIGENS
抗前列腺癌抗原的重组抗体
- 批准号:
7561507 - 财政年份:2007
- 资助金额:
$ 10.05万 - 项目类别: